AKTX vs TGTX
Akari Therapeutics, Plc · TG Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | AKTX | TGTX |
|---|---|---|
| Price | $7.00 | $49.76 |
| Market Cap | $640.97B | $7.62B |
| P/E | — | 17.03 |
| P/B | 44573.65 | 13.06 |
| P/S | 1742346.13 | 12.36 |
| ROE | -120.3% | 76.7% |
| Net Margin | -4702.1% | 72.6% |
| Gross Margin | — | — |
| Revenue Growth | -39.5% | 87.3% |
| Dividend Yield | — | — |
| EPS | -$0.00 | $2.92 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.